Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Published Aug 17, 2020

Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Patients and doctors are encouraged that clinical trials have started up again. A leading expert talks to SurvivorNet about why you shouldn't be afraid to consider a clinical trial during the outbreak.

NOW
PLAYING
Terminal Cancer Mom Debates Surgery to Extend Life Amid Fears COVID Will Kill Her
NOW
PLAYING
A Leukemia Patient Unable to Get Vaccinated Has Died from COVID at 41; Should People with Blood Cancer Get the Vaccine?
NOW
PLAYING
COVID Vaccines Are Far Less Effective in Most Cancer Patients, Ineffective in Some, According to New Research
NOW
PLAYING
'Life or Death': Cancer Patients Face Postponed Surgeries, Treatments Due to Fourth COVID Wave
NOW
PLAYING
FDA Set to Approve Third COVID-19 Booster Shot For Cancer Patients
NOW
PLAYING
Does Your Cancer Center Require Employees To Be Vaccinated? How Cancer Patients Can Stay Safe From The Delta Variant During COVID-19

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.